Cell Line Development

Cell Line Development

Cobra had developed a proprietary CHO-S mammalian expression system and high throughput cell line development platform called MaxXpress, based on the UCOE system, which was developed at Cobra.

Cobra Biologics

Booth:
  • 1359

Cobra Biologics - contract development and manufacturing excellence

Leading international contract development and manufacturing organization (CDMO) of biologics and pharmaceuticals for clinical and commercial supply, Cobra has three GMP-approved facilities in Sweden ...Leading international contract development and manufacturing organization (CDMO) of biologics and pharmaceuticals for clinical and commercial supply, Cobra has three GMP-approved facilities in Sweden and the UK, offering a range of integrated and stand-alone contract development and manufacturing services covering antibodies, recombinant proteins, viruses, DNA, whole cell vaccines, microbiota, small molecule API, lyophilisation and fill finish. Cobra has recently embarked on a £15m operations expansion to fast track our customers’ portfolios through to in-market supply. Cobra is looking to meet biotech/ pharmaceutical companies interested in outsourcing the production of their clinical trial material. www.cobrabio.com @Cobrabiologics More

View Company Profile

More products from this Company:

  • DNA

    Grades of DNA offered: Non-GMP, High Quality (HQ), and GMP plasmid DNA for preclinical and clinical supply. Cobra is a solution provider for DNA va...

  • Viral Vectors

    Cobra has been a manufacturer of cGMP viral vector products for gene therapies and viral vaccines since 2002. Cobra develops robust and scalable proc...

  • Mammalian Protein Services

    Cobra offers a full range of Mammalian protein services for pre-clinical through to Phase III clinical trials and commercial supply including Cell L...

  • Fill Finish of Biologics and...

    Cobra Biologics’ fill finish facility located in Matfors (Sweden) provides contract manufacturing services for human and veterinary clinical trial an...

We use cookies to operate this website and to improve its usability. Full details of what cookies are, why we use them and how you can manage them can be found by reading our Privacy & Cookies page. Please note that by using this site you are consenting to the use of cookies.